Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment.

Hou YC, Lai CH.

Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):319-20. doi: 10.9758/cpn.2015.13.3.319.

2.

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.

Dhir A, Kulkarni SK.

Eur J Pharmacol. 2007 Jul 30;568(1-3):177-85. Epub 2007 May 4.

PMID:
17509558
3.

Bupropion: a review of its mechanism of antidepressant activity.

Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, et al.

J Clin Psychiatry. 1995 Sep;56(9):395-401. Review.

PMID:
7665537
4.

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.

Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S.

Prim Care Companion J Clin Psychiatry. 2004;6(4):159-166.

6.

Studies of bupropion's mechanism of antidepressant activity.

Ferris RM, Cooper BR, Maxwell RA.

J Clin Psychiatry. 1983 May;44(5 Pt 2):74-8. Review.

PMID:
6406468
7.

Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion.

Evans L, Golshan S, Kelsoe J, Rapaport M, Resovsky K, Sutton L, Gillin JC.

Neuropsychopharmacology. 2002 Dec;27(6):1016-26.

8.
9.

Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.

El Mansari M, Ghanbari R, Janssen S, Blier P.

Neuropharmacology. 2008 Dec;55(7):1191-8. doi: 10.1016/j.neuropharm.2008.07.028. Epub 2008 Jul 30.

PMID:
18708076
11.

Bupropion in depression. I. Biochemical effects and clinical response.

Golden RN, Rudorfer MV, Sherer MA, Linnoila M, Potter WZ.

Arch Gen Psychiatry. 1988 Feb;45(2):139-43.

PMID:
3122698
12.

Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.

Kale PP, Addepalli V.

Pharmacol Biochem Behav. 2014 Sep;124:238-44. doi: 10.1016/j.pbb.2014.06.005. Epub 2014 Jun 14.

PMID:
24933334
13.

Bupropion: new therapy for depression.

Feinberg M.

Am Fam Physician. 1990 Jun;41(6):1787-90. Review.

PMID:
2112333
14.
15.

Acute psychosis following sustained release bupropion overdose.

Wang TS, Shiah IS, Yeh CB, Chang CC.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):149-51. Epub 2004 Nov 23.

PMID:
15610958
16.
17.

Bupropion for depression in schizophrenia.

Englisch S, Inta D, Eer A, Zink M.

Clin Neuropharmacol. 2010 Sep-Oct;33(5):257-9. doi: 10.1097/WNF.0b013e3181f5a5f9.

PMID:
20852411
19.

Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.

Hudson AL, Lalies MD, Silverstone P.

Can J Physiol Pharmacol. 2012 Jun;90(6):803-9. doi: 10.1139/y2012-045. Epub 2012 Apr 18.

PMID:
22512539
20.

Bupropion Hydrochloride.

Khan SR, Berendt RT, Ellison CD, Ciavarella AB, Asafu-Adjaye E, Khan MA, Faustino PJ.

Profiles Drug Subst Excip Relat Methodol. 2016;41:1-30. doi: 10.1016/bs.podrm.2015.12.001. Epub 2016 Feb 17. Review.

PMID:
26940167

Supplemental Content

Support Center